Literature DB >> 28351071

Neurologic Deficits Have a Negative Impact on Patient-Related Outcomes in Primary Presentation Adult Symptomatic Lumbar Scoliosis Surgical Treatment at One-Year Follow-up.

Daniel G Kang1, Christine Baldus1, Steven D Glassman2, Christopher I Shaffrey3, Jon D Lurie4, Keith H Bridwell1.   

Abstract

STUDY
DESIGN: A retrospective analysis of prospective, multicenter National Institute of Health clinical trial.
OBJECTIVE: The aim of this study was to assess the rate of neurologic complications and impact of new neurologic deficits on 1-year postoperative patient-reported outcomes (PROs). SUMMARY OF BACKGROUND DATA: There are limited studies evaluating the impact of new neurologic deficits on PROs following surgery for primary presentation adult lumbar scoliosis.
METHODS: Patients were divided into two groups: new postoperative neurological deficit (Def) or no deficit (NoDef). Preoperative and 1-year follow-up PROs were analyzed [Scoliosis Research Society (SRS) Questionnaire, Oswestry Disability Index (ODI), Short Form-12 Physical/Mental Health Composite Scores (PCS/MCS), and back/leg pain Numerical Rating Scale (NRS)].
RESULTS: One hundred forty-one patients: 14 Def (9.9%), 127 NoDef (90.1%). No differences were observed in demographic, radiographic, or PRO data between groups preoperatively. Def group had longer surgical procedures (8.3 vs. 6.9 hours, P = 0.030), greater blood loss (2832 vs. 2606 mL, P = 0.022), and longer hospitalizations (10.6 vs. 7.8 days, P = 0.004). NoDef group reported significant improvement in all PROs from preop to 1-year postoperative. Def group only had improvement in SRS Pain (2.7 preop to 3.4 postop, P = 0.037) and self-image domains (2.7 to 3.6, p = 0.004), and NRS back pain (6.6 to 3.2, P = 0.004) scores with significant worsening of NRS leg pain (4.1 to 6.1, P = 0.045). Group comparisons of 1-year postop PROs found that Def group reported more NRS leg pain (6.1 vs. 1.7, P < 0.001) and worse outcomes than NoDef group for ODI (35.7 vs. 23.1, P = 0.016) and PCS (32.6 vs. 41.9, P = 0.007).
CONCLUSION: We found a 9.9% rate of new neurologic deficits following surgery for symptomatic primary presentation adult lumbar scoliosis, much higher than previous studies. Most neurologic deficits improved by 1-year follow-up, but appeared to have a dramatic negative impact on PROs, with increased postoperative leg pain and greater patient-perceived pathology reported in patients experiencing neurological deficits compared with those who did not. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2017        PMID: 28351071      PMCID: PMC5373095          DOI: 10.1097/BRS.0000000000001800

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.241


  14 in total

Review 1.  Medical complications of surgical treatment of adult spinal deformity and how to avoid them.

Authors:  Eli M Baron; Todd J Albert
Journal:  Spine (Phila Pa 1976)       Date:  2006-09-01       Impact factor: 3.468

2.  Iatrogenic paraplegia in spinal surgery.

Authors:  K-S Delank; H W Delank; D P König; F Popken; S Fürderer; P Eysel
Journal:  Arch Orthop Trauma Surg       Date:  2004-12-23       Impact factor: 3.067

3.  Complications and risk factors of primary adult scoliosis surgery: a multicenter study of 306 patients.

Authors:  Sebastien Charosky; Pierre Guigui; Arnaud Blamoutier; Pierre Roussouly; Daniel Chopin
Journal:  Spine (Phila Pa 1976)       Date:  2012-04-15       Impact factor: 3.468

4.  Lumbar nerve root palsy after adult spinal deformity surgery.

Authors:  Dhruv B Pateder; John P Kostuik
Journal:  Spine (Phila Pa 1976)       Date:  2005-07-15       Impact factor: 3.468

5.  Adult spinal deformity surgery: complications and outcomes in patients over age 60.

Authors:  Michael D Daubs; Lawrence G Lenke; Gene Cheh; Georgia Stobbs; Keith H Bridwell
Journal:  Spine (Phila Pa 1976)       Date:  2007-09-15       Impact factor: 3.468

Review 6.  Functional and radiographic outcomes after surgery for adult scoliosis using third-generation instrumentation techniques.

Authors:  Raed M Ali; Oheneba Boachie-Adjei; Bernard A Rawlins
Journal:  Spine (Phila Pa 1976)       Date:  2003-06-01       Impact factor: 3.468

7.  The impact of perioperative complications on clinical outcome in adult deformity surgery.

Authors:  Steven D Glassman; Christopher L Hamill; Keith H Bridwell; Frank J Schwab; John R Dimar; Thomas G Lowe
Journal:  Spine (Phila Pa 1976)       Date:  2007-11-15       Impact factor: 3.468

8.  Complications in long fusions to the sacrum for adult scoliosis: minimum five-year analysis of fifty patients.

Authors:  Joseph K Weistroffer; Joseph H Perra; John E Lonstein; James D Schwender; Timothy A Garvey; Ensor E Transfeldt; James W Ogilvie; Francis Denis; Robert B Winter; Jill M Wroblewski
Journal:  Spine (Phila Pa 1976)       Date:  2008-06-01       Impact factor: 3.468

9.  Health outcome assessment before and after adult deformity surgery. A prospective study.

Authors:  T J Albert; J Purtill; J Mesa; T McIntosh; R A Balderston
Journal:  Spine (Phila Pa 1976)       Date:  1995-09-15       Impact factor: 3.468

10.  Late complications of adult idiopathic scoliosis primary fusions to L4 and above: the effect of age and distal fusion level.

Authors:  Anthony Rinella; Keith Bridwell; Yongjung Kim; Jonas Rudzki; Charles Edwards; Michael Roh; Lawrence Lenke; Annette Berra
Journal:  Spine (Phila Pa 1976)       Date:  2004-02-01       Impact factor: 3.468

View more
  1 in total

1.  Effect of Serious Adverse Events on Health-related Quality of Life Measures Following Surgery for Adult Symptomatic Lumbar Scoliosis.

Authors:  Justin S Smith; Christopher I Shaffrey; Michael P Kelly; Elizabeth L Yanik; Jon D Lurie; Christine R Baldus; Charles Edwards; Steven D Glassman; Lawrence G Lenke; Oheneba Boachie-Adjei; Jacob M Buchowski; Leah Y Carreon; Charles H Crawford; Thomas J Errico; Stephen J Lewis; Tyler Koski; Stefan Parent; Han Jo Kim; Christopher P Ames; Shay Bess; Frank J Schwab; Keith H Bridwell
Journal:  Spine (Phila Pa 1976)       Date:  2019-09-01       Impact factor: 3.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.